AgiBot targets Hong Kong IPO with Citic, CICC, Morgan Stanley as sponsors
Synopsis
AgiBot, one of China's fastest-growing humanoid robot makers, is pursuing a Hong Kong IPO with Citic Securities, CICC, and Morgan Stanley as joint sponsors, targeting a valuation of up to HK$50 billion (US$6.41 billion) — a landmark bet on the commercialisation of robotics.
Key Takeaways
AgiBot , a Shanghai -based humanoid robot developer, is pursuing an IPO on the Hong Kong Stock Exchange , according to two people familiar with the matter.
Three joint sponsors have been appointed: Citic Securities , China International Capital Corporation (CICC) , and Morgan Stanley .
The company is reportedly targeting a valuation of HK$40 billion (US$5.10 billion) to HK$50 billion , per a 2025 Reuters report.
AgiBot completed a conversion from a limited liability company to a joint-stock limited firm last year — a required step before going public.
The planned listing joins a wave of major HKEX candidates including Shein and Zhongji Innolight , whose IPO targets US$8 billion with a debut set for 30 July .
Rivals in the Chinese robotics space include Unitree Robotics , Deep Robotics , and Leju Robotics .
Shanghai-based humanoid robot maker AgiBot is pursuing an initial public offering (IPO) on the Hong Kong stock exchange and has engaged three major financial institutions as joint sponsors, according to two people familiar with the matter. The move signals a formal step toward a public listing for one of China's fastest-growing robotics companies.
Three heavyweight sponsors on board
Citic Securities, China International Capital Corporation (CICC), and Morgan Stanley have been hired as joint sponsors for the planned offering, one of the sources said. AgiBot, Citic Securities, CICC, and Morgan Stanley did not immediately respond to requests for comment as of Wednesday, 22 July 2026.
Structural groundwork already laid
AgiBot had been signalling its listing ambitions after completing a corporate restructuring — converting from a limited liability company to a joint-stock limited firm last year, a mandatory prerequisite for companies preparing to go public in China or Hong Kong. The conversion is widely regarded by market observers as a reliable indicator of near-term IPO intent.
Valuation target: up to HK$50 billion
The Shanghai-based robotics developer had been eyeing a Hong Kong listing this year, reportedly targeting a valuation of between HK$40 billion (US$5.10 billion) and HK$50 billion, according to a Reuters report from 2025. If achieved, the listing would rank among the more significant technology debuts on the Hong Kong Stock Exchange (HKEX) in recent years.
Why it matters: a wave of marquee listings hits Hong Kong
AgiBot's planned IPO is part of a broader surge of high-profile candidates targeting HKEX, including fast-fashion giant Shein and optical transceiver manufacturer Zhongji Innolight. Innolight's IPO — potentially the city's biggest listing in seven years — attracted more than 30 cornerstone investors and aimed to raise US$8 billion, with a market debut scheduled for 30 July.
What's next for AgiBot
AgiBot competes in a crowded and rapidly evolving humanoid and quadruped robotics sector alongside rivals including Unitree Robotics, Deep Robotics, and Leju Robotics. A successful listing would give the company a significant capital advantage to accelerate hardware development, expand manufacturing capacity, and compete for enterprise and industrial contracts globally. Investors will be watching whether AgiBot can sustain its growth trajectory and justify valuations in a sector where commercialisation timelines remain uncertain.
Point of View
International investor access, and a higher-profile stage at a time when Beijing is actively promoting robotics as a strategic industry. What mainstream coverage underplays is the valuation risk — at up to HK$50 billion, AgiBot would be priced on promise rather than proven revenue, in a sector where hardware margins are thin and deployment at scale remains unproven. The presence of Morgan Stanley alongside Chinese banks also suggests the company is actively courting Western institutional capital, a notable move given ongoing geopolitical friction around dual-use technology.
NationPress
22 Jul 2026
Frequently Asked Questions
What is AgiBot and why is it pursuing a Hong Kong IPO?
AgiBot is a Shanghai -based humanoid and advanced robotics company that is pursuing an IPO on the Hong Kong Stock Exchange to raise capital for expansion. The company has engaged Citic Securities , CICC , and Morgan Stanley as joint sponsors, according to people familiar with the matter.
What valuation is AgiBot targeting for its Hong Kong IPO?
AgiBot is reportedly targeting a valuation of between HK$40 billion (US$5.10 billion) and HK$50 billion for its planned Hong Kong listing, according to a 2025 Reuters report. The final valuation will depend on investor demand and market conditions at the time of the offering.
Who are AgiBot's main competitors in the robotics sector?
AgiBot competes with several prominent Chinese robotics firms including Unitree Robotics , Deep Robotics , and Leju Robotics . The humanoid robotics sector in China is intensely competitive, with multiple players racing to achieve commercial-scale deployment.
Why is Hong Kong attracting so many major tech IPOs in 2026?
Hong Kong is experiencing a resurgence of high-profile listing candidates, including Shein and Zhongji Innolight , whose IPO aims to raise US$8 billion — potentially the city's biggest in seven years . The exchange offers Chinese companies access to international capital while operating under a familiar regulatory framework.
What steps has AgiBot taken to prepare for an IPO?
AgiBot converted from a limited liability company to a joint-stock limited firm last year, which is a mandatory prerequisite for companies seeking to list publicly in Hong Kong or mainland China . The appointment of three joint sponsors — Citic Securities , CICC , and Morgan Stanley — marks a further formal step in the IPO process.
